Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

The RECLAIM Study.

NCT: NCT06450444 · RECRUITING

NCT IDNCT06450444
StatusRECRUITING
Start Date2024-06-24
Completion2029-01-31

Brief Summary

The purpose of this study is to evaluate the safety and performance, including clinical benefit, of the PRIMUS System for the treatment of Resistant Migraine.

Frequently Asked Questions

What is The RECLAIM Study.?

The RECLAIM Study. is a clinical trial registered under NCT06450444. Current status: RECRUITING.

What is the status of NCT06450444?

The current status of NCT06450444 (The RECLAIM Study.) is: RECRUITING.

When did The RECLAIM Study. start?

The RECLAIM Study. started on 2024-06-24.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.